# VTP-1000 in Adults With Celiac Disease

> **NCT06310291** · EARLY_PHASE1 · RECRUITING · sponsor: **Barinthus Biotherapeutics** · enrollment: 45 (estimated)

## Conditions studied

- Celiac Disease

## Interventions

- **BIOLOGICAL:** VTP-1000
- **OTHER:** Matched Placebo

## Key facts

- **NCT ID:** NCT06310291
- **Lead sponsor:** Barinthus Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06310291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06310291, "VTP-1000 in Adults With Celiac Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06310291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*